SubHero Banner

Milprosa(progesterone) – New drug approval

April 29, 2020 - The FDA approved Ferring Pharmaceuticals’ Milprosa (progesterone), to support embryo implantation and early pregnancy (up to 10 weeks post-embryo transfer) by supplementation of corpus luteal function as part of an Assisted Reproductive Technology (ART) treatment program for infertile women up to and including 34 years of age.

Download PDF